Becton, Dickinson and Company (BDX) Stake Lowered by GW Henssler & Associates Ltd.

GW Henssler & Associates Ltd. lowered its holdings in Becton, Dickinson and Company (NYSE:BDX) by 5.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,549 shares of the medical instruments supplier’s stock after selling 1,287 shares during the period. GW Henssler & Associates Ltd.’s holdings in Becton, Dickinson and were worth $4,418,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in BDX. Alliancebernstein L.P. grew its position in shares of Becton, Dickinson and by 0.8% in the first quarter. Alliancebernstein L.P. now owns 366,807 shares of the medical instruments supplier’s stock valued at $67,287,000 after purchasing an additional 2,817 shares during the period. Spark Investment Management LLC purchased a new stake in shares of Becton, Dickinson and in the first quarter valued at $366,000. Montag & Caldwell LLC purchased a new stake in shares of Becton, Dickinson and in the first quarter valued at $34,713,000. AXA grew its position in shares of Becton, Dickinson and by 7.1% in the first quarter. AXA now owns 420,553 shares of the medical instruments supplier’s stock valued at $77,146,000 after purchasing an additional 27,846 shares during the period. Finally, MAI Capital Management purchased a new stake in shares of Becton, Dickinson and in the first quarter valued at $218,000. 86.01% of the stock is owned by institutional investors and hedge funds.

In related news, insider Gary M. Cohen sold 15,512 shares of the business’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $203.77, for a total value of $3,160,880.24. Following the transaction, the insider now owns 95,781 shares in the company, valued at $19,517,294.37. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Linda M. Tharby sold 4,695 shares of the business’s stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $200.48, for a total value of $941,253.60. Following the completion of the transaction, the executive vice president now owns 18,670 shares in the company, valued at approximately $3,742,961.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 47,038 shares of company stock worth $9,480,225. 1.40% of the stock is currently owned by insiders.

A number of research analysts recently weighed in on the company. Stifel Nicolaus reiterated a “buy” rating and issued a $245.00 target price on shares of Becton, Dickinson and in a report on Friday, November 3rd. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $230.00 target price (up previously from $210.00) on shares of Becton, Dickinson and in a report on Friday, November 3rd. Morgan Stanley lifted their target price on Becton, Dickinson and from $205.00 to $245.00 and gave the company an “equal weight” rating in a report on Friday, November 3rd. Wells Fargo & Company reiterated a “positive” rating and issued a $235.00 target price (up previously from $225.00) on shares of Becton, Dickinson and in a report on Tuesday, October 24th. They noted that the move was a valuation call. Finally, Zacks Investment Research upgraded Becton, Dickinson and from a “sell” rating to a “hold” rating in a report on Friday, October 20th. Five research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $213.47.

Becton, Dickinson and Company (BDX) opened at $220.00 on Tuesday. The company has a market capitalization of $49,889.07, a PE ratio of 23.10, a price-to-earnings-growth ratio of 1.72 and a beta of 1.04. Becton, Dickinson and Company has a one year low of $161.29 and a one year high of $225.23. The company has a debt-to-equity ratio of 1.48, a quick ratio of 5.01 and a current ratio of 5.56.

Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Thursday, November 2nd. The medical instruments supplier reported $2.40 EPS for the quarter, topping the Zacks’ consensus estimate of $2.37 by $0.03. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.14 billion. Becton, Dickinson and had a return on equity of 22.51% and a net margin of 8.52%. The firm’s quarterly revenue was down 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.12 earnings per share. sell-side analysts expect that Becton, Dickinson and Company will post 10.63 EPS for the current year.

WARNING: This report was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://sportsperspectives.com/2017/11/14/becton-dickinson-and-company-bdx-stake-lowered-by-gw-henssler-associates-ltd.html.

Becton, Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply